This is a non-core endpoint: only basic statistics are computed.
Toxic effect of other inorganic substances
ST19_TOXIC_EFFECT_OTHER_INORG_SUBST
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
23 |
4. Check minimum number of eventsNone |
23 |
5. Include endpointsNone |
23 |
6. Filter based on genotype QC (FinnGen only) |
23 |
Control definitions (FinnGen only)
- Control exclude
- ST19_TOXIC_EFFEC_SUBST_CHIEF_NONME_SOURCE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T5[1-9]|T6[0-5]
- Name in latin
- Effectus toxicus aliarum substantiarum non organicarum
Similar endpoints
↥List of similar endpoints to
Toxic effect of other inorganic substances
based on the number of shared cases.
Similar with more cases:
- Toxic effects of substances chiefly nonmedicinal as to source
- Injury, poisoning and certain other consequences of external causes
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 23 | 9 | 14 |
| Unadjusted period prevalence (%) | 0.00 | 0.00 | 0.01 |
| Median age at first event (years) | 46.48 | 42.25 | 49.20 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
9
18
7.46
3.85
1.8
2.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
7
19
4.81
2.37
3.3
8.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
14
5.38
2.32
3.5
5.4
mmol/l
25.2
25.6
—
6
14
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
13
67
3.16
1.86
3.7
2.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
7
26
3.41
1.75
1.1
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
9
42
2.86
1.57
1.9
1.9
—
—
—
0
0
(3015736) pH of Urine
13
72
2.85
1.57
4.2
3.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
11
57
2.78
1.48
3.1
2.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
8
34
3.06
1.48
1.4
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
10
50
2.77
1.43
9.0
4.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
9
49
2.37
1.17
6.3
6.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
23
199
+∞
1.05
16.7
13.7
mg/l
25.8
26.0
0.01
18
154
(3011397) Hemoglobin [Presence] in Urine by Test strip
8
44
2.25
0.99
4.1
2.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
11
67
2.23
0.97
2.6
1.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
7
38
2.20
0.83
2.0
1.9
mg/l
2.0
3.3
—
7
29
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
25
2.27
0.78
1.2
2.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
5
25
2.27
0.78
1.2
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
17
133
2.06
0.74
4.9
4.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
12
83
1.93
0.71
9.0
4.6
%
0.8
0.6
1.12
12
75
(3006504) Eosinophils/100 leukocytes in Blood
12
83
1.93
0.71
9.0
4.6
%
2.4
2.8
0.28
12
76
(3019069) Monocytes/100 leukocytes in Blood
12
83
1.93
0.71
9.1
4.9
%
9.9
8.9
0.62
12
77
(3044640) Blood type and Crossmatch panel - Blood
10
65
1.95
0.70
1.7
1.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
12
84
1.90
0.67
9.0
4.4
%
54.4
58.1
0.54
12
78
(40761511) CBC panel - Blood by Automated count
23
207
+∞
0.62
11.9
13.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
12
86
1.83
0.61
9.1
4.6
%
28.4
27.5
0.12
12
79
(3013707) Erythrocyte sedimentation rate by Westergren method
17
145
1.66
0.44
4.4
3.4
mm/h
10.1
13.3
0.61
17
129
(3017181) Myelocytes/100 leukocytes in Blood
0
15
0.00
0.43
0.0
3.8
—
0.6
—
0
5
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
7
50
1.57
0.37
1.7
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
8
65
1.35
0.32
2.5
2.4
nmol/l
92.0
72.0
—
8
56
(3021960) Folate [Moles/volume] in Serum or Plasma
5
41
1.28
0.24
1.6
1.4
nmol/l
22.0
22.4
—
5
31
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
12
101
1.39
0.23
2.8
3.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
0
11
0.00
0.22
0.0
7.1
—
22.0
—
0
11
(3022621) pH of Urine by Test strip
0
11
0.00
0.22
0.0
2.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
0
11
0.00
0.22
0.0
1.7
—
166.5
—
0
11
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.22
0.0
2.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
11
0.00
0.22
0.0
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
0
10
0.00
0.22
0.0
5.8
—
—
—
0
0
(3019225) pH of Specimen
0
10
0.00
0.22
0.0
3.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
0
10
0.00
0.22
0.0
2.3
—
4.6
—
0
10
(3019060) Gas panel - Arterial blood
0
12
0.00
0.22
0.0
5.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
7
56
1.36
0.21
5.6
3.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
0
14
0.00
0.21
0.0
3.9
—
0.2
—
0
5
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
7
87
0.72
0.19
5.4
4.3
ug/l
2.8
2.1
—
7
78
(3044889) 12 lead EKG panel
12
135
0.77
0.15
2.4
3.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
5
44
1.17
0.11
7.4
7.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
16
148
1.27
0.09
8.3
7.3
u/l
69.3
77.7
0.60
16
137
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
13
128
1.04
0.00
3.8
3.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
7
75
0.90
0.00
2.4
2.3
ug/l
48.3
134.8
—
7
62
(3038515) Glucose [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
4.3
—
6.8
—
0
6
(40768793) Breast Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
553.0
—
0
8
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
3.8
—
3.9
—
0
5
(1616796) Gas panel - Central venous blood
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
5
57
0.84
0.00
5.8
3.0
ug/l
0.6
0.8
—
5
38
(3003338) MCHC [Mass/volume]
18
174
1.16
0.00
28.2
16.9
g/l
334.3
334.1
0.03
18
174
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
23
224
+∞
0.00
25.7
18.7
pg
30.4
30.4
0.05
23
219
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3024731) MCV [Entitic volume]
23
224
+∞
0.00
25.6
18.7
fl
90.9
90.6
0.07
23
219
(3014051) Protein [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
7
0.00
0.00
0.0
7.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
4.4
—
0
7
(3035285) Chloride [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
3.8
—
107.6
—
0
5
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
0
8
0.00
0.00
0.0
2.3
—
2.1
—
0
8
(4034850)
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
0.5
—
0
9
(3007930) Methemoglobin/Hemoglobin.total in Blood
0
9
0.00
0.00
0.0
6.8
—
0.6
—
0
9
(3022313) Gas panel - Capillary blood
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
23
223
+∞
0.00
25.8
18.8
e9/l
245.4
248.3
0.10
23
216
(3008037) Lactate [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
4.3
—
1.1
—
0
6
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
23
224
+∞
0.00
26.2
18.8
g/l
136.0
138.4
0.40
23
219
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
7
70
1.00
0.00
4.6
4.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_TOXIC_EFFECT_OTHER_INORG_SUBST – Toxic effect of other inorganic substances
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).